Chips & deep tech · Official
Claude Speeds Drug Development: Early Progress With Six Partner Companies
Anthropic News (community mirror) ·
At a glance
Anthropic's life sciences team worked closely with six companies that make medicines for several months. Claude is helping at many stages of drug development.
Key points
- Partner companies include BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.
- Drug development is divided into several stages, including finding targets, designing molecules, optimizing large-scale manufacturing, and preparing clinical trial documents.
- Anthropic has also started its own drug research aimed at rare diseases such as childhood Duchenne muscular dystrophy.
- Generate Biomedicines says it used Claude Code to change the genetic design of a CAR T cell therapy and got better results in the lab.
Why it matters
It is an important record showing, in real-world settings, whether AI can change how quickly new medicines come to market.
Original source
Early progress on accelerating drug development with Claude
Anthropic News (community mirror) · Oct 27, 09:00 KST
Read on Anthropic News (community mirror) ↗AI summarized the original article. Check the original for accuracy. Copyright belongs to Anthropic News (community mirror).
More from this field
- Daniel Ek Backs Europa Fusion, a Stealthy UK Fusion Startup Led by an AI Researcher
Spotify founder Daniel Ek is backing Europa Fusion, a stealth startup in the UK. Its founder, Nantas Nardelli, is an AI researcher who left Pacific Fusion to pursue fusion power with a different approach. The startup plans to focus more on simulations and data than on physical hardware.
TechCrunch · Nov 21, 04:53 KST - Nvidia Board Ousted Jensen Huang Mainly Over Lying, Sources Say
Nvidia's board reportedly pushed out CEO Jensen Huang mainly over his repeated lying, not just the affair allegations. Sources say he lied about his relationships and what he told the board over about a year.
WIRED · Nov 21, 04:52 KST - AWS CloudFormation StackSets Adds Custom Execution Roles and Nested Stack Support
AWS CloudFormation StackSets now lets service-managed stack sets use custom execution roles. This lets you limit what StackSets can do in each account. Nested stacks, macros, and transforms also work with these stack sets.
AWS What's New · Nov 21, 02:45 KST - Plurilock Shareholders Approve Acquisition by Quantum eMotion
Shareholders of Plurilock Security voted overwhelmingly to approve its planned acquisition by Quantum eMotion. The vote covered a plan of arrangement, a legal structure for the deal. The company is now asking a Canadian court for a final approval before the deal can close.
Quantum Computing Report · Nov 21, 01:40 KST